Sunitinib

Inhibits multiple receptor tyrosine kinases (VEGFR, PDGFR, KIT, FLT3, RET)

No curated interaction pairs are recorded for Sunitinib. This is not a statement that none exist — check a full interaction reference before combining.

• Fatigue
• Diarrhea
• Nausea
• Mucositis
• Skin discoloration
• Hypertension

Half-life

40-60 hours (80-110 hours for active metabolite)

Protein binding

95%

Metabolised by

CYP3A4

Not recorded for Sunitinib. Absence here means this database does not hold a category — not that the drug is safe in pregnancy or breastfeeding.